Hochschulschrift
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
- Weitere Titel
-
Erläuterung der Mechanismen zur Krankheitsresistenz und Persistenz bei chronischer myeloischer Leukämie
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Marburg, Philipps-Universität Marburg, Diss., 2011
- Schlagwort
-
Chronisch-myeloische Leukämie
Imatinib mesilat
Resistenz
Endokrinologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Marburg
- (wer)
-
Philipps-Universität Marburg
- (wann)
-
2011
- Urheber
- Beteiligte Personen und Organisationen
-
Burchert, Andreas
- URN
-
urn:nbn:de:hebis:04-z2011-04590
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Kumari, Ashu
- Burchert, Andreas
- Philipps-Universität Marburg
Entstanden
- 2011
Ähnliche Objekte (12)
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
IKK2-inhibition targets TNF-induced leukemic stem cell persistence in chronic myeloid leukemia
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Treatment-free remission in chronic myeloid leukemia
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
Novel imantib resistance mechanisms in chronic myeloid leukemia
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Myeloid cells and therapy resistance in chronic lymphocytic leukemia
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
Bosutinib in chronic myeloid leukemia : patient selection and perspectives
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
Atypical presentation of patients with chronic myeloid leukemia in chronic phase : Case report
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
IKK2-inhibition targets TNF-induced leukemic stem cell persistence in chronic myeloid leukemia
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Treatment-free remission in chronic myeloid leukemia
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
Novel imantib resistance mechanisms in chronic myeloid leukemia
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Myeloid cells and therapy resistance in chronic lymphocytic leukemia
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
Bosutinib in chronic myeloid leukemia : patient selection and perspectives
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
Atypical presentation of patients with chronic myeloid leukemia in chronic phase : Case report
Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia
IKK2-inhibition targets TNF-induced leukemic stem cell persistence in chronic myeloid leukemia
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Treatment-free remission in chronic myeloid leukemia
Somatic variant profiling in chronic phase pediatric chronic myeloid leukemia
Novel imantib resistance mechanisms in chronic myeloid leukemia
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Myeloid cells and therapy resistance in chronic lymphocytic leukemia
Myeloid cells and therapy resistance in Chronic Lymphocytic Leukemia
Bosutinib in chronic myeloid leukemia : patient selection and perspectives
The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase